{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:28:31Z","timestamp":1773876511690,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02006-y","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T04:44:31Z","timestamp":1754023471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and predictors of diabetic kidney disease among type 2 diabetes mellitus adult patients in Ethiopia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Muluken Amare","family":"Wudu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarikua Afework","family":"Birhanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirubel Dagnaw","family":"Tegegne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endalk Birrie","family":"Wondifraw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2006_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"K Alfred","year":"2021","unstructured":"Alfred K, Changchang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99:S1\u201387. https:\/\/doi.org\/10.1016\/j.kint.2020.11.003.","journal-title":"Kidney Int"},{"key":"2006_CR2","unstructured":"International Diabetes Federation, Diabetes Atlas IDF. International Diabetes Federation, Brussels, Belgium, 10th edition, 2021, https:\/\/www.diabetesatlas.org"},{"key":"2006_CR3","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021. Results. Institute for Health Metrics and Evaluation. 2024 (https:\/\/vizhub.healthdata.org\/gbd-results\/)."},{"key":"2006_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cegh.2020.05.016","volume":"9","author":"S Hussain","year":"2021","unstructured":"Hussain S, Jamali MC, Habib A, Hussain MS, Akhtar M, Najmi AK. Diabetic kidney disease: an overview of prevalence, risk factors, and biomarkers. Clin Epidemiol Global Health. 2021;9:2\u20136. https:\/\/doi.org\/10.1016\/j.cegh.2020.05.016.","journal-title":"Clin Epidemiol Global Health"},{"key":"2006_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","volume":"22","author":"NM Selby","year":"2020","unstructured":"Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metabolism. 2020;22:3\u201315. https:\/\/doi.org\/10.1111\/dom.14007.","journal-title":"Diabetes Obes Metabolism"},{"key":"2006_CR6","doi-asserted-by":"publisher","unstructured":"Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Renal fibrosis: mechanisms and therapies. 2019:3\u201315. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_1","DOI":"10.1007\/978-981-13-8871-2_1"},{"issue":"1","key":"2006_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13098-023-01202-x","volume":"15","author":"ET Fenta","year":"2023","unstructured":"Fenta ET, Eshetu HB, Kebede N, Bogale EK, Zewdie A, Kassie TD, Anagaw TF, Mazengia EM, Gelaw SS. Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis. Diabetol Metab Syndr. 2023;15(1):245. https:\/\/doi.org\/10.1186\/s13098-023-01202-x.","journal-title":"Diabetol Metab Syndr"},{"key":"2006_CR8","doi-asserted-by":"publisher","unstructured":"Gerber C et al. Incidence and progression of chronic kidney disease in black and white individuals with type 2 diabetes. Clinical Journal of the American Society of Nephrology, 2018. 13(6): pp. 884\u2013892. https:\/\/doi.org\/10.2215\/CJN.11871017 PMID: 29798889.","DOI":"10.2215\/CJN.11871017"},{"issue":"4","key":"2006_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.pcd.2019.11.002","volume":"14","author":"A Gonza\u00b4lez-Pe\u00b4rez","year":"2020","unstructured":"Gonza\u00b4lez-Pe\u00b4rez A, et al. Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the united Kingdom. Prim Care Diabetes. 2020;14(4):381\u20137. https:\/\/doi.org\/10.1016\/j.pcd.2019.11.002. PMID: 31791904.","journal-title":"Prim Care Diabetes"},{"key":"2006_CR10","doi-asserted-by":"publisher","unstructured":"Koye DN et al. Trends in the incidence of ESKD in people with type 1 and type 2 diabetes in Australia, 2002\u20132013. American Journal of Kidney Diseases, 2019. 73(3): pp. 300\u2013308. https:\/\/doi.org\/10.1053\/jajkd.2018.10.005. PMID: 30579709.","DOI":"10.1053\/jajkd.2018.10.005"},{"issue":"3","key":"2006_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000491708","volume":"140","author":"MH Tsai","year":"2018","unstructured":"Tsai MH, Hsu CY, Lin MY, Yen MF, Chen HH, Chiu YH, Hwang SJ. Incidence, prevalence, and duration of chronic kidney disease in taiwan: results from a community-based screening program of 106,094 individuals. Nephron. 2018;140(3):175\u201384. https:\/\/doi.org\/10.1159\/000491708. PMID: 30138926.","journal-title":"Nephron"},{"issue":"1","key":"2006_CR12","doi-asserted-by":"publisher","first-page":"20234","DOI":"10.1038\/s41598-023-47091-y","volume":"13","author":"D Xie","year":"2023","unstructured":"Xie D, Ma T, Cui H, Li J, Zhang A, Sheng Z, Xie Y. Global burden and influencing factors of chronic kidney disease due to type 2 diabetes in adults aged 20\u201359 years, 1990\u20132019. Sci Rep. 2023;13(1):20234. https:\/\/doi.org\/10.1038\/s41598-023-47091-y.","journal-title":"Sci Rep"},{"issue":"1","key":"2006_CR13","doi-asserted-by":"publisher","first-page":"8890331","DOI":"10.1155\/2020\/8890331","volume":"2020","author":"WS Shiferaw","year":"2020","unstructured":"Shiferaw WS, Akalu TY, Aynalem YA. Chronic kidney disease among diabetes patients in ethiopia: a systematic review and meta-analysis. Int J Nephrol. 2020;2020(1):8890331. https:\/\/doi.org\/10.1155\/2020\/8890331.","journal-title":"Int J Nephrol"},{"issue":"5","key":"2006_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.4093\/dmj.2020.0109","volume":"45","author":"Moazzeni SS","year":"2021","unstructured":"Moazzeni SS, Arani RH, Hasheminia M, Tohidi M, Azizi F, Hadaegh F. High incidence of chronic kidney disease among Iranian diabetic adults: using CKD-EPI and MDRD equations for estimated glomerular filtration rate. Diabetes Metabolism J. 2021;45(5):684\u201397. https:\/\/doi.org\/10.4093\/dmj.2020.0109.","journal-title":"Diabetes Metabolism J"},{"key":"2006_CR15","unstructured":"International Diabetes Federation, Diabetes Atlas IDF. International Diabetes Federation, Brussels, Belgium, 9th edition, 2019."},{"issue":"1","key":"2006_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41581-020-00363-6","volume":"17","author":"VA Luyckx","year":"2021","unstructured":"Luyckx VA, Al-Aly Z, Bello AK, Bellorin-Font E, Carlini RG, Fabian J, Garcia-Garcia G, Iyengar A, Sekkarie M, Van Biesen W, Ulasi I. Sustainable development goals relevant to kidney health: an update on progress. Nat Rev Nephrol. 2021;17(1):15\u201332.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2006_CR17","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello AK, Okpechi IG, Levin A, Ye F, Damster S, Arruebo S, Donner JA, Caskey FJ, Cho Y, Davids MR, Davison SN. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Global Health. 2024;12(3):e382\u201395. https:\/\/www.theisn.org\/wpcontent\/uploads\/media\/ISN%20Atlas_2023%20Digital_REV_2023_10_03.pdf.","journal-title":"Lancet Global Health"},{"key":"2006_CR18","doi-asserted-by":"crossref","unstructured":"Fernandez RM. SDG3 good health and well-being: integration and connection with other SDGs. Good health and well-being. 2020:629\u2013\u200936.","DOI":"10.1007\/978-3-319-95681-7_64"},{"key":"2006_CR19","unstructured":"Ethiopia Federal Minister of Health. Standard Treatment Guideline for General Hospital, fourth Edition, Addis Ababa 2021."},{"key":"2006_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3618-9","volume":"11","author":"AH Geletu","year":"2018","unstructured":"Geletu AH, Teferra AS, Sisay MM, Teshome DF. Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at st. Paul\u2019s hospital, addis ababa, Ethiopia. BMC Res Notes. 2018;11:1\u20136. https:\/\/doi.org\/10.1186\/s13104-018-3618-9.","journal-title":"BMC Res Notes"},{"issue":"5","key":"2006_CR21","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.dsx.2020.06.028","volume":"14","author":"K Tamru","year":"2020","unstructured":"Tamru K, Aga F, Berhanie E, Aynalem YA, Shiferaw WS. Incidence of diabetic kidney disease in patients with type 2 diabetes mellitus at a tertiary healthcare setting in Ethiopia. Diabetes Metabolic Syndrome: Clin Res Reviews. 2020;14(5):1077\u201383. https:\/\/doi.org\/10.1016\/j.dsx.2020.06.028.","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"issue":"1","key":"2006_CR22","doi-asserted-by":"publisher","first-page":"6757916","DOI":"10.1155\/2021\/6757916","volume":"2021","author":"SA Kebede","year":"2021","unstructured":"Kebede SA, Tusa BS, Weldesenbet AB, Tessema ZT, Ayele TA. Incidence of diabetic kidney disease and its predictors among type 2 diabetes mellitus patients at university of Gondar comprehensive specialized hospital, Northwest Ethiopia. J Nutr Metabolism. 2021;2021(1):6757916. https:\/\/doi.org\/10.1155\/2021\/6757916.","journal-title":"J Nutr Metabolism"},{"key":"2006_CR23","doi-asserted-by":"publisher","unstructured":"Debele GR, Hajure M, Wolde HF, Yenit MK. Incidence and predictors of chronic kidney disease among diabetes mellitus patients: a retrospective follow-up study at a tertiary health-care setting of ethiopia. Diabetes, metabolic syndrome and obesity. 2021 Oct 28:4381\u201390. https:\/\/doi.org\/10.2147\/DMSO.S335572","DOI":"10.2147\/DMSO.S335572"},{"issue":"1","key":"2006_CR24","doi-asserted-by":"publisher","first-page":"e0263138","DOI":"10.1371\/journal.pone.0263138","volume":"17","author":"MA Ahmed","year":"2022","unstructured":"Ahmed MA, Ferede YM, Takele WW. Incidence and predictors of chronic kidney disease in type-II diabetes mellitus patients attending at the Amhara region referral hospitals, ethiopia: a follow-up study. PLoS ONE. 2022;17(1):e0263138. https:\/\/doi.org\/10.1371\/journal.pone.0263138.","journal-title":"PLoS ONE"},{"key":"2006_CR25","doi-asserted-by":"publisher","unstructured":"Tekalign T, Guta MT, Awoke N, Chichiabellu TY, Meskele M, Anteneh G, Tura TS, Workie SB. Time to diabetic kidney disease and its predictors among diabetic patients treated in Wolaita and Dawuro zone hospitals, ethiopia: a retrospective cohort study. Int J Nephrol Renovascular Disease 2023 Dec 31:163\u201372. https:\/\/doi.org\/10.2147\/IJNRD.S396574","DOI":"10.2147\/IJNRD.S396574"},{"issue":"1","key":"2006_CR26","doi-asserted-by":"publisher","first-page":"6976870","DOI":"10.1155\/2024\/6976870","volume":"2024","author":"F Merid","year":"2024","unstructured":"Merid F, Getahun F, Esubalew H, Gezahegn T. Incidence and predictors of diabetic kidney disease among type 2 diabetes mellitus patients, Southern Ethiopia. J Nutr Metabolism. 2024;2024(1):6976870. https:\/\/doi.org\/10.1155\/2024\/6976870.","journal-title":"J Nutr Metabolism"},{"key":"2006_CR27","doi-asserted-by":"publisher","first-page":"1290554","DOI":"10.3389\/fpubh.2023.1290554","volume":"11","author":"A Cheru","year":"2024","unstructured":"Cheru A, Edessa D, Regassa LD, Gobena T. Incidence and predictors of chronic kidney disease among patients with diabetes treated at governmental hospitals of Harari region, Eastern ethiopia, 2022. Front Public Health. 2024;11:1290554. https:\/\/doi.org\/10.3389\/fpubh.2023.1290554.","journal-title":"Front Public Health"},{"key":"2006_CR28","doi-asserted-by":"publisher","DOI":"10.11124\/jbies-22-00224","author":"Z Munn","year":"2022","unstructured":"Munn Z, Stone J, Aromataris E, Klugar M, Sears K, Leonardi-Bee J, Barker T. Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews. JBI Evid Synthesis. 2022. https:\/\/doi.org\/10.11124\/jbies-22-00224.","journal-title":"JBI Evid Synthesis"},{"key":"2006_CR29","doi-asserted-by":"publisher","unstructured":"Glasgow M, Edlin R, Harding J. Comparison of risk-of-bias assessment approaches for selection of studies reporting prevalence for economic analyses. BMJ Open. 2020;10. https:\/\/doi.org\/10.1136\/bmjopen-2020-037324.","DOI":"10.1136\/bmjopen-2020-037324"},{"key":"2006_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-015-0091-1","volume":"15","author":"C R\u00f6ver","year":"2015","unstructured":"R\u00f6ver C, Knapp G, Friede T. Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med Res Methodol. 2015;15:1\u20137. https:\/\/doi.org\/10.1186\/s12874-015-0091-1.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"2006_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SA. A new improved graphical and quantitative method for detecting bias in meta-analysis. JBI Evid Implement. 2018;16(4):195\u2013203. https:\/\/doi.org\/10.1097\/XEB.0000000000000141.","journal-title":"JBI Evid Implement"},{"issue":"3","key":"2006_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/kidneydial2030038","volume":"2","author":"EK Hoogeveen","year":"2022","unstructured":"Hoogeveen EK. The epidemiology of diabetic kidney disease. Kidney Dialysis. 2022;2(3):433\u201342. https:\/\/doi.org\/10.3390\/kidneydial2030038.","journal-title":"Kidney Dialysis"},{"key":"2006_CR33","doi-asserted-by":"publisher","first-page":"101932","DOI":"10.1016\/j.arr.2023.101932","volume":"88","author":"N Ray","year":"2023","unstructured":"Ray N, Reddy PH. Structural and physiological changes of the kidney with age and its impact on chronic conditions and COVID-19. Ageing Res Rev. 2023;88:101932. https:\/\/doi.org\/10.1016\/j.arr.2023.101932.","journal-title":"Ageing Res Rev"},{"issue":"9","key":"2006_CR34","doi-asserted-by":"publisher","first-page":"e076261","DOI":"10.1136\/bmjopen-2023-076261","volume":"13","author":"SD Shuvo","year":"2023","unstructured":"Shuvo SD, Hossen MT, Riazuddin M, Hossain MS, Mazumdar S, Parvin R, Elahi MT. Prevalence of comorbidities and its associated factors among type-2 diabetes patients: a hospital-based study in Jashore district, Bangladesh. BMJ Open. 2023;13(9):e076261. https:\/\/doi.org\/10.1136\/bmjopen-2023-076261.","journal-title":"BMJ Open"},{"key":"2006_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12889-016-3335-z","volume":"16","author":"J Li","year":"2016","unstructured":"Li J, Green M, Kearns B, et al. Patterns of Multimorbidity and their association with health outcomes within yorkshire, england: baseline results from the Yorkshire health study. BMC Public Health. 2016;16:649. https:\/\/doi.org\/10.1186\/s12889-016-3335-z.","journal-title":"BMC Public Health"},{"key":"2006_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17:83. https:\/\/doi.org\/10.1186\/s12933-018-0728-6.","journal-title":"Cardiovasc Diabetol"},{"key":"2006_CR37","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1016\/j.je.2016.12.012","volume":"27","author":"H Yokomichi","year":"2017","unstructured":"Yokomichi H, Nagai A, Hirata M, et al. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer, and smoking in patients with type 2 diabetes: biobank Japan cohort. J Epidemiol. 2017;27:S98\u2013106. https:\/\/doi.org\/10.1016\/j.je.2016.12.012.","journal-title":"J Epidemiol"},{"key":"2006_CR38","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.3390\/ijerph19159333","volume":"19","author":"A Bernabe-Ortiz","year":"2022","unstructured":"Bernabe-Ortiz A, Borjas-Cavero DB, P\u00e1ucar-Alfaro JD, et al. Multimorbidity patterns among people with type 2 diabetes mellitus: findings from Lima. Peru IJERPH. 2022;19:9333. https:\/\/doi.org\/10.3390\/ijerph19159333.","journal-title":"Peru IJERPH"},{"issue":"4","key":"2006_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/hr.2010.263","volume":"34","author":"JB Lopes de Faria","year":"2011","unstructured":"Lopes de Faria JB, Silva KC, Lopes de Faria JM. The contribution of hypertension to diabetic kidney disease and retinopathy: the role of inflammation and oxidative stress. Hypertens Res. 2011;34(4):413\u201322. https:\/\/doi.org\/10.1038\/hr.2010.263.","journal-title":"Hypertens Res"},{"key":"2006_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3670-5","volume":"11","author":"F Wagnew","year":"2018","unstructured":"Wagnew F, Eshetie S, Kibret GD, Zegeye A, Dessie G, Mulugeta H, Alemu A. Diabetic kidney disease and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis. BMC Res Notes. 2018;11:1\u20137. https:\/\/doi.org\/10.1186\/s13104-018-3670-5.","journal-title":"BMC Res Notes"},{"issue":"1","key":"2006_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jch.13768","volume":"22","author":"M Wang","year":"2020","unstructured":"Wang M, Li J, Li Y, Yao S, Zhao M, Wang C, Wu S, Xue H. The effects of hypertension and diabetes on new-onset chronic kidney disease: a prospective cohort study. J Clin Hypertens. 2020;22(1):39\u201346. https:\/\/doi.org\/10.1111\/jch.13768.","journal-title":"J Clin Hypertens"},{"issue":"1","key":"2006_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12889-022-12509-1","volume":"22","author":"H Alsaadon","year":"2022","unstructured":"Alsaadon H, Afroz A, Karim A, Habib SH, Alramadan MJ, Billah B, Shetty AN. Hypertension and its related factors among patients with type 2 diabetes mellitus\u2013a multi-hospital study in Bangladesh. BMC Public Health. 2022;22(1):198. https:\/\/doi.org\/10.1186\/s12889-022-12509-1.","journal-title":"BMC Public Health"},{"issue":"1","key":"2006_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","volume":"21","author":"CX Ma","year":"2022","unstructured":"Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21(1):74. https:\/\/doi.org\/10.1186\/s12933-022-01516-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2006_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/dci23-0041","volume":"47","author":"N Sattar","year":"2024","unstructured":"Sattar N, Presslie C, Rutter MK, McGuire DK. Cardiovascular and kidney risks in individuals with type 2 diabetes: contemporary Understanding with greater emphasis on excess adiposity. Diabetes Care. 2024;47(4):531\u201343. https:\/\/doi.org\/10.2337\/dci23-0041.","journal-title":"Diabetes Care"},{"issue":"2","key":"2006_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","volume":"3","author":"AD Shah","year":"2015","unstructured":"Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, Deanfield J, Smeeth L, Timmis A, Hemingway H. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b7 9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105\u201313. https:\/\/doi.org\/10.1016\/S2213-8587(14)70219-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"22","key":"2006_CR46","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.3390\/jcm12226984","volume":"12","author":"S Swamy","year":"2023","unstructured":"Swamy S, Noor SM, Mathew RO. Cardiovascular disease in diabetes and chronic kidney disease. J Clin Med. 2023;12(22):6984. https:\/\/doi.org\/10.3390\/jcm12226984.","journal-title":"J Clin Med"},{"issue":"5","key":"2006_CR47","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1097\/MS9.0000000000001951","volume":"86","author":"RT Annose","year":"2024","unstructured":"Annose RT, Asefa H, Gezahagn Y, Abebe G, Zewde TH. Determinants of cardiovascular disease among type 2 diabetic patients attending diabetic follow-up clinic in Arba minch general hospital, Southern ethiopia: an unmatched case-control study. Annals Med Surg. 2024;86(5):2467\u201373. https:\/\/doi.org\/10.1097\/MS9.0000000000001951.","journal-title":"Annals Med Surg"},{"issue":"3","key":"2006_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.ackd.2014.03.003","volume":"21","author":"R P\u00e1lsson","year":"2014","unstructured":"P\u00e1lsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21(3):273\u201380. https:\/\/doi.org\/10.1053\/j.ackd.2014.03.003.","journal-title":"Adv Chronic Kidney Dis"},{"key":"2006_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/9781118494073.ch7","volume":"10","author":"M Busch","year":"2013","unstructured":"Busch M. Cardiovascular disease in diabetic nephropathy: pathophysiology and treatment. Diabetes and kidney disease. Jan. 2013;10:83\u2013100. https:\/\/doi.org\/10.1002\/9781118494073.ch7.","journal-title":"Jan"},{"issue":"1","key":"2006_CR50","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12916-024-03810-4","volume":"22","author":"DT Lui","year":"2024","unstructured":"Lui DT, Li L, Liu X, Xiong X, Tang EH, Lee CH, Woo YC, Lang BH, Wong CK, Tan KC. The association of HDL-cholesterol levels with incident major adverse cardiovascular events and mortality in 0.6 million individuals with type 2 diabetes: a population-based retrospective cohort study. BMC Med. 2024;22(1):586. https:\/\/doi.org\/10.1186\/s12916-024-03810-4.","journal-title":"BMC Med"},{"issue":"11","key":"2006_CR51","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2337\/dc12-0306","volume":"35","author":"J Morton","year":"2012","unstructured":"Morton J, Zoungas S, Li Q, Patel AA, Chalmers J, Woodward M, Celermajer DS, Beulens JW, Stolk RP, Glasziou P, Ng MK. Low HDL cholesterol and the risk of diabetic kidney disease and retinopathy: results of the ADVANCE study. Diabetes Care. 2012;35(11):2201\u20136. https:\/\/doi.org\/10.2337\/dc12-0306.","journal-title":"Diabetes Care"},{"issue":"2","key":"2006_CR52","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4093\/dmj.2017.41.2.128","volume":"41","author":"S Palazhy","year":"2017","unstructured":"Palazhy S, Viswanathan V. Lipid abnormalities in type 2 diabetes mellitus patients with overt nephropathy. Diabetes Metabolism J. 2017;41(2):128. https:\/\/doi.org\/10.4093\/dmj.2017.41.2.128.","journal-title":"Diabetes Metabolism J"},{"key":"2006_CR53","doi-asserted-by":"publisher","first-page":"1272314","DOI":"10.3389\/fendo.2024.1272314","volume":"15","author":"Z Yan","year":"2024","unstructured":"Yan Z, Xu Y, Li K, Liu L. Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus: dual evidence from NHANES database and Mendelian randomization analysis. Front Endocrinol. 2024;15:1272314. https:\/\/doi.org\/10.3389\/fendo.2024.1272314.","journal-title":"Front Endocrinol"},{"key":"2006_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.metabol.2017.05.004","volume":"73","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Kieneker LM, Bakker SJL, James RW, Dullaart RPF. Incident type 2 diabetes is associated with hdl, but not with its anti-oxidant constituent - paraoxonase-1: the prospective cohort prevend study. Metabolism. 2017;73:43\u2013515. https:\/\/doi.org\/10.1016\/j.metabol.2017.05.004.","journal-title":"Metabolism"},{"key":"2006_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/imm.12638","volume":"149","author":"SG Thacker","year":"2016","unstructured":"Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, et al. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology. 2016;149:306\u2013195. https:\/\/doi.org\/10.1111\/imm.12638.","journal-title":"Immunology"},{"key":"2006_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2022.02.012","volume":"345","author":"BF Asztalos","year":"2022","unstructured":"Asztalos BF, Hauser TH, Goldfine AB, Welty FK, Horvath KV, Schaefer EJ. The role of hdl- and non-hdl-related parameters in cell-cholesterol efflux capacity. Atherosclerosis. 2022;345:1\u201365. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.02.012.","journal-title":"Atherosclerosis"},{"key":"2006_CR57","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.120.050808","volume":"143","author":"C Jia","year":"2021","unstructured":"Jia C, Anderson JLC, Gruppen EG, Lei Y, Bakker SJL, Dullaart RPF, et al. High-density lipoprotein anti-inflammatory capacity and incident cardiovascular events. Circulation. 2021;143:1935\u2013455. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050808.","journal-title":"Circulation"},{"key":"2006_CR58","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/cells10030574","volume":"10","author":"MP Adorni","year":"2021","unstructured":"Adorni MP, Ronda N, Bernini F, Zimetti F. High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: pathophysiological aspects and Pharmacological perspectives. Cells. 2021;10:574. https:\/\/doi.org\/10.3390\/cells10030574.","journal-title":"Cells"},{"key":"2006_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/EJE-14-0195","volume":"171","author":"YC Hwang","year":"2014","unstructured":"Hwang YC, Ahn HY, Park SW, Park CY. Association of hdl-c and Apolipoprotein a-i with the risk of type 2 diabetes in subjects with impaired fasting glucose. Eur J Endocrinol. 2014;171:137\u2013425. https:\/\/doi.org\/10.1530\/EJE-14-0195.","journal-title":"Eur J Endocrinol"}],"updated-by":[{"DOI":"10.1186\/s12902-025-02021-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000}}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02006-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02006-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02006-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:17:21Z","timestamp":1757326641000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02006-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02006-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12902-025-02021-z","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12902-025-02021-z","URL":"https:\/\/doi.org\/10.1186\/s12902-025-02021-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was registered in a database called PROSPERO (, CRD42025643160). This study was evaluated and approved by the Wollo University College of Medicine and Health Science Research and Community Service Committee with reference No_(WU\/CMHS\/20\/543\/2025) and ethical clearance was obtained. Moreover, this study was conducted in compliance with the PRISMA guidelines to ensure that our review was thorough and reliable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Muluken Amare Wudu is a senior lecturer in Department of Pediatrics and Child Health Nursing, College of Medicine and Health Sciences, Wollo University, 1145, Dessie, Ethiopia: Endalik Birrie Wondifraw is a senior lecturer in the Department of Pediatrics and Child Health Nursing, College of Medicine and Health Sciences, Wollo University, 1145, Dessie, Ethiopia; Kirubel Dagnaw Tegegne is an assistant professor of Adult Health Nursing and working in senior lecturer Department of Adult Health Nursing, College of Medicine and Health Sciences College of Medicine and Health Sciences, Wollo University, 1145, Dessie, Ethiopia; Tarikua Afework Birhanu is lecturer in in Department of Pediatrics and Child Health Nursing, College of Medicine and Health Sciences, Wollo University, 1145, Dessie, Ethiopia.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors information\u2019s"}}],"article-number":"190"}}